• HPV has been associated with cancers of both men and women

             – Cervical (*100%), Oropharyngeal SCC (-60%), Penile, Vaginal/Vulvar, and Anal

•  The probability that a sexually active male will get a new genital HPV infection (12 month period) is 0.29-0.3
• However, there is a difference in immune response that is seen in men and women

              – HPV Seropositivity: 17.9% Fvs. 7.9% M

• The quadrivalent HPV vaccine has been shown to be efficacious in preventing persistent infection and genital disease in females

              – Active against types 6, 11, 16, 18

Click Here to Efficacy of a Human Papillomavirus Vaccination Educational Platform in a Diverse Urban Population